RESMED INC — Director's Dealing 2016

Mar 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2016-03-15

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-15	ResMed Common Stock	M	5975	$33.70	Acquired	150852	Direct
2016-03-15	ResMed Common Stock	S	5975	$58.57	Disposed	144877	Direct
2016-03-16	ResMed Common Stock	A	8097	—	Acquired	152974	Direct
2016-03-16	ResMed Common Stock	F	4226	—	Disposed	148748	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-15	ResMed Common Stock Options	$33.70	M	5975	Disposed	2017-11-11	ResMed Commmon Stock (5975)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 annually.

F3: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted March 1, 2013, with a three-year performance period. The shares were earned and vested March 16, 2016, when the ResMed compensation committee certified performance.

F4: Shares earned, based on performance, at 40% of the target award.

F5: Disposition to issuer for tax withholding on vesting of performance-based restricted stock units granted March 1, 2013.